scispace - formally typeset
K

Kanwal K. Nischal

Researcher at University of Pittsburgh

Publications -  9
Citations -  407

Kanwal K. Nischal is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Rubeosis iridis. The author has an hindex of 3, co-authored 7 publications receiving 291 citations. Previous affiliations of Kanwal K. Nischal include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

IC3D Classification of Corneal Dystrophies—Edition 2

Jayne S. Weiss, +15 more
- 01 Feb 2015 - 
TL;DR: This revision of the IC3D classification includes an updated anatomic classification of corneal dystrophy more accurately classifying TGFBI dystrophies that affect multiple layers rather than are confined to one cornean layer.
Journal ArticleDOI

Drug delivery systems and novel formulations to improve treatment of rare corneal disease.

Jorge Jimenez, +3 more
- 12 Mar 2019 - 
TL;DR: The barriers to effective drug delivery and proposed solutions in development will be discussed along with an overview of corneal rare disease resources, their current treatments and ophthalmic drug delivery systems that could benefit such cases.
Journal ArticleDOI

Forceps trauma in a newborn presenting as iris heterochromia.

Sarah M. Simpson, +3 more
- 01 Oct 2017 - 
TL;DR: The first case of ocular birth trauma from forceps presenting as isolated iris heterochromia and a pseudo rubeosis iridis is reported, which completely resolved by 1 month of age with no known adverse ocular sequelae.
Journal ArticleDOI

NYX-related Congenital Stationary Night Blindness in Two Siblings due to Probable Maternal Germline Mosaicism.

Hannah L. Scanga, +6 more
- 24 Jun 2021 - 
TL;DR: In this paper, a retrospective chart review of a single pedigree was performed, which demonstrated the possibility of maternal mosaicism in Congenital Stationary Night Blindness (CSNB) related to a hemizygous variant of NYX.
Journal ArticleDOI

Biochemical and molecular alterations and potential clinical applications of biomarkers in keratoconus

Vaitheeswaran Ganesan Lalgudi, +5 more
- 01 Jan 2022 - 
TL;DR: Understanding of the several novel factors which have the potential to be biomarkers in addressing several unanswered questions in the disease process could help in the better predictive ability of progression or vision loss and customization of treatment options.